18:58 , Jul 13, 2018 |  BC Week In Review  |  Financial News

Sinovac Terminates Take-Private Deal, Raises $86.7M

Vaccines company Sinovac Biotech Ltd. (NASDAQ:SVA) said July 3 it raised $86.7 million in a private placement and terminated a planned deal to take the company private. A special committee formed by the company's board determined...
18:09 , Jul 3, 2018 |  BC Extra  |  Financial News

Sinovac terminates take-private deal, raises $86.7M

Vaccines company Sinovac Biotech Ltd. (NASDAQ:SVA) said it raised $86.7 million in a private placement and terminated a planned deal to take the company private. A special committee formed by the company's board determined that it...
19:25 , Jan 26, 2018 |  BC Week In Review  |  Financial News

Harbour BioMed raises undisclosed series A+

Harbour BioMed (Shanghai, China) raised an undisclosed series A+ round on Jan. 22 led by new investor CDH Investments. Existing investor Advantech Capital participated. This month, Harbour granted BeiGene Ltd. (NASDAQ:BGNE) and ImmunoChina Pharmaceuticals Co. Ltd....
00:08 , Jan 23, 2018 |  BC Extra  |  Financial News

CDH leads Harbour BioMed round

Harbour BioMed (Shanghai, China) raised an undisclosed series A+ round led by new investor CDH Investments. Existing investor Advantech Capital participated. This month, Harbour granted BeiGene Ltd. (NASDAQ:BGNE) and ImmunoChina Pharmaceuticals Co. Ltd. rights to its...
19:08 , Jan 19, 2018 |  BioCentury  |  Finance

Incubating in China

C-Bridge Capital is one of the newer venture funds in Chinese healthcare seeking to bring mature platforms or programs from the Western market into China. Compared with most other Chinese VCs, however, C-Bridge is investing...
21:20 , Jan 5, 2018 |  BC Week In Review  |  Financial News

DTRM Biopharma closes series A round

Zhejiang DTRM Biopharma Co. Ltd. (Zhejiang, China) raised a series A round on Jan. 2 worth more than $60 million, with components in two currencies. The round included a $45.9 million component led by Advantech...
20:45 , Jan 5, 2018 |  BC Week In Review  |  Financial News

Chinese biotech KBP raises $76 million series A

KBP Biosciences Co. Ltd. (Jinan, China) raised a $76 million series A round on Jan. 5 co-led by Advantech Capital and SDIC Venture Capital, with participation from Sangel Capital, Ping An Ventures, Bay City Capital...
13:06 , Jan 5, 2018 |  BC Extra  |  Financial News

Chinese biotech KBP raises $76 million series A

KBP Biosciences Co. Ltd. (Jinan, China) raised a $76 million series A round co-led by Advantech Capital and SDIC Venture Capital, with participation from Sangel Capital, Ping An Ventures, Bay City Capital GF XINDE Life...
20:54 , Jan 2, 2018 |  BC Extra  |  Financial News

DTRM Biopharma raises series A round

Zhejiang DTRM Biopharma Co. Ltd. (Zhejiang, China) raised a series A round worth more than $60 million, with components in two currencies. The round included a $45.9 million component led by Advantech Capital, and a...
19:16 , Sep 15, 2017 |  BC Week In Review  |  Company News

Harbour gets Chinese rights to HanAll's biologics

Korean biotech HanAll Biopharma Co. Ltd. (KOSDAQ:009420) granted Harbour BioMed (Shanghai, China) rights to develop and commercialize HL161 and HL036 for multiple indications in China, including Hong Kong and Macau, and Taiwan. HanAll retains rights...